This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
saas: Archive
Qorvo (QRVO)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
QRVONegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy 3D Systems (DDD) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
DDDPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Can Visa's New PingPong Deal Unlock B2B Payment Growth?
by Rajshree Sipani
V expands B2B payments with PingPong, enabling cross-border supplier payouts via commercial cards across 170+ countries.
MAPositive Net Change VNegative Net Change AXPNegative Net Change
business-services fin-tech finance payments saas
After Golden Cross, Siemens AG (SIEGY)'s Technical Outlook is Bright
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
SIEGYPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Here's Why You Should Retain Paychex Stock in Your Portfolio
by Zacks Equity Research
PAYX gains 7.9% over the past month as SaaS demand, AI-driven HR tools and expanding PEO services support its growth outlook.
PAYXNegative Net Change ANETNegative Net Change DOCUNegative Net Change
computers saas tech-stocks
Can Workday's New Sana AI Solutions for Enterprises Boost Its Shares?
by Zacks Equity Research
WDAY rolls out Sana for ITSM and a new Travel Agent, adding AI agents that automate IT support and travel-to-expense workflows in a single platform.
ADPNegative Net Change ORCLNegative Net Change WDAYNegative Net Change
artificial-intelligence automation business-services saas tech-stocks
Salesforce Heads into Earnings with Everything to Prove - And Everything to Gain
by Bryan Hayes
The share-price chart and the operating reality have been telling very different stories.
CRMNegative Net Change
artificial-intelligence automation cloud-computing cybersecurity datacenter earnings investing saas software tech-stocks
Should You Buy UBS (UBS) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
UBSNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Everpure Gears Up to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
P heads into fiscal Q1 FY2027 earnings with revenue seen up about 28%, fueled by hyperscaler and AI-driven demand amid component cost pressures.
CRMNegative Net Change DGPositive Net Change DELLNegative Net Change PPositive Net Change
artificial-intelligence cloud-computing computers saas tech-stocks
Agentforce to Boost Salesforce's Subscription Revenue Growth in Q1
by Zacks Equity Research
CRM heads into Q1 earnings results with Agentforce momentum fueling AI bookings, customer growth and stronger subscription revenue trends.
CRMNegative Net Change ATENPositive Net Change TEAMNegative Net Change BILLNegative Net Change
artificial-intelligence computers earnings saas tech-stocks